Long-read Genome Sequencing for the Molecular Diagnosis of Dystonia

NANot yet recruitingINTERVENTIONAL
Enrollment

150

Participants

Timeline

Start Date

August 31, 2025

Primary Completion Date

August 31, 2030

Study Completion Date

August 31, 2030

Conditions
DystoniaMovement DisordersCombined DystoniaComplex Dystonia
Interventions
DIAGNOSTIC_TEST

Long-read whole genome sequencing

Pseudonymized blood samples will undergo high-molecular-weight DNA extraction, followed by long-read whole-genome sequencing (lrWGS) using Oxford Nanopore technology. Index cases will be sequenced at high depth (\>30X), while relatives will be multiplexed (\>15X). Sequencing data will be analyzed through a dedicated bioinformatics pipeline to detect SNVs, indels, structural variants, and repeat expansions. Results will be interpreted by expert teams and discussed in monthly clinical-genetic meetings. Variants of interest will be validated by appropriate molecular techniques, and family segregation will be assessed when relevant.

All Listed Sponsors
lead

University Hospital, Strasbourg, France

OTHER

NCT06999096 - Long-read Genome Sequencing for the Molecular Diagnosis of Dystonia | Biotech Hunter | Biotech Hunter